An update from the practice-changing DREAMseq (EA6134) trial for melanoma, results of a pancreas cancer trial (E2211), health equity findings, and the latest from the NCI-MATCH precision medicine trial are among a mix of abstracts
Philadelphia, May 17, 2022 — Researchers with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present a wide range of abstracts at the annual meeting of the American Society of Clinical Oncology (ASCO), occurring June 3-7 in Chicago and online. The data include evaluations of new approaches to cancer treatment, control, care delivery, and health equity. The National Cancer Institute, part of the National Institutes of Health, funded these studies.
ASCO will release the full abstracts on Thursday, May 26 at 5:00 PM (ET). Abstracts are under the ASCO news embargo until then. To request an interview with one of the authors, send an email to Diane Dragaud, Director of Communications, or call 215-789-3631. Please follow the ASCO 2022 Annual Meeting Media Policies.